Arrowhead Pharmaceuticals
ARWR
#3749
Rank
NZ$4.81 B
Marketcap
$38.68
Share price
2.38%
Change (1 day)
-14.07%
Change (1 year)

P/S ratio for Arrowhead Pharmaceuticals (ARWR)

P/S ratio as of December 2024 (TTM): 784

According to Arrowhead Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 14.6. At the end of 2024 the company had a P/S ratio of 689.

P/S ratio history for Arrowhead Pharmaceuticals from 2001 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20246893706.91%
202318.19.07%
202216.6-65.44%
202148.0-51.41%
202098.8151.89%
201939.261.22%
201824.3169.8%
20179.01-64.88%
201625.7-98.22%
2015> 10007.55%
2014> 1000-44.71%
2013> 10001936.39%
2012119-93.55%
2011> 100012700.49%
201014.439.13%
200910.3-57.95%
200824.6-72.88%
200790.6-78.6%
2006424111.8%
20052006.9%
2004187547.7%
200328.9126.56%
200212.7-11.98%
200114.5

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
15.0-98.08%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
15.2-98.07%๐Ÿ‡บ๐Ÿ‡ธ USA
276-64.81%๐Ÿ‡บ๐Ÿ‡ธ USA
3.95-99.50%๐Ÿ‡บ๐Ÿ‡ธ USA
3.18-99.59%๐Ÿ‡บ๐Ÿ‡ธ USA